The Directigen 1,2,3 Group A Strep Test (DGAST; BBL Microbiology Systems, Cockeysville, Md.) was compared with conventional culture methods for the detection of group A streptococci. Among 327 children, the DGAST had a sensitivity of 75.0%, a specificity of 99.1%, and positive and negative predictive values of 97.5 and 89.3%, respectively, as compared with 48-h culture results. The lower sensitivity (60.0%) in 322 adults was related to the low incidence of group A streptococcal pharyngitis in that population (7.8%). The positive and negative predictive values for adults were 93.8 and 96.7%, respectively. Only 3 of 327 (0.9%) pediatric and 2 of 322 (0.6%) adult specimens yielded uninterpretable results in the DGAST.
The diagnosis of streptococcal pharyngitis has traditionally relied upon microbiological culturing performed in the laboratory. Recently, antigen detection methods have become sufficiently sensitive to detect group A streptococcal (GAS) antigens extracted directly from throat swabs (1-4, 7, 8) . As commercial products for the direct rapid detection of GAS have become available, the diagnosis of streptococcal pharyngitis has shifted from the microbiology laboratory to the physician's office (6, 10, 11) .
Rapid antigen detection systems for GAS have shown a wide range of sensitivities (62 to 95%), but the specificities are generally high (85 to 100%) (5, (12) (13) (14) (9) . On the basis of reference culture methods incorporating both selective and nonselective media incubated for 48 h, these investigators reported that the DGAST produced an unacceptable number of false-positive and false-negative tests and concluded that culturing was still required to prevent missed diagnoses.
The present study was undertaken to determine the utility of the DGAST for the diagnosis of acute streptococcal pharyngitis in patients from a high-incidence pediatric population as compared with a low-incidence adult population in the same community.
Two patient populations in Iowa City, Iowa, were evaluated for GAS pharyngitis between 20 March and 12 (5) .
Agreement between culturing and the DGAST was 98.4% for cultures with 4+ growth from both patient populations. For both populations, the correlation between DGAST positivity and 3+ growth was 82.4%; the corresponding values for 2+ growth and 1+ growth were 58.8 and 26.5%, respectively.
Of the beta-hemolytic colonies examined, 37.7% (78 of 207) were not GAS (8 group B, 50 group C, 13 group F, and 7 group G). No cross-reactivity between the DGAST and non-group A beta-hemolytic streptococci occurred, as indicated by the high specificity observed. However, six cultures initially identified as GAS by the BBL direct immunofluorescence fluorescein isothiocyanate conjugate were subsequently shown to be group C streptococci by latex agglutination.
The sensitivity and specificity obtained in this evaluation of the DGAST were considerably better than those reported by Huck et al. (9) . While our specificity based upon 48-h culture results was somewhat higher than that obtained in the studies cited in the product insert (99 versus 92%), our sensitivity was considerably lower (72 versus 90%) for combined specimens. in whom the incidence of GAS pharyngitis is high and in whom most specimens produce >1+ culture results.
In summary, the DGAST was evaluated with pharyngeal specimens from 649 patients equally divided between a high-incidence pediatric population and a low-incidence adult population. The cumulative sensitivity (72.1%), specificity (99.4%), positive predictive value (96.9%), and negative predictive value (93.4%) were higher than previously reported; however, these values may vary with the population tested and the reference methods used. The DGAST may be used most effectively in the screening of acutely ill symptomatic patients, in whom the incidence of GAS pharyngitis is high. Because of the low sensitivity as compared with that of the culture method used in our laboratory, we recommend that all negative DGAST results be followed up with culturing.
